Molecular neuroscience at its “high”: bibliometric analysis of the most cited papers on endocannabinoid system, cannabis and cannabinoids

作者: Andy Wai Kan Yeung , Nikolay T. Tzvetkov , Nicolas Arkells , Luigi Milella , Adrian M. Stankiewicz

DOI: 10.1186/S42238-019-0004-Y

关键词:

摘要: Cannabis, cannabinoids and endocannabinoids are heavily investigated topics with many articles published every year. We aimed to identify the 100 most cited manuscripts among vast literature analyze their contents. Web of Science (WoS) Core Collection was searched relevant manuscripts, which were analyzed reference (1) authorship, (2) institution, (3) country, (4) document type, (5) journal, (6) publication year, (7) WoS category, (8) citation count. Semantic content data VOSviewer. The between 1986 2016, majority being in 2000s (n = 51). number citations for top ranged from 469 3651, a median count 635.5. prolific authors Vincenzo Di Marzo (n = 11) Daniele Piomelli (n = 11). major contributing countries USA (n = 49), Italy (n = 22), UK (n = 19), France institutions University California (n = 14), National Research Council (n = 12) Institutes Health (n = 12). consisted original (n = 75), reviews (n = 24) note (n = 1). dominant journal Nature (n = 15). categories associated Multidisciplinary sciences (n = 31), Neurosciences (n = 20), Pharmacology / Pharmacy (n = 16), General Internal Medicine top-ranked concerning analgesia, weight loss, long-term potentiation, depolarization-induced suppression inhibition, opiates other topics. Cannabinoid type 1 (CB1) receptor studied by more papers comparison cannabinoid 2 (CB2) receptor. frequently mentioned chemicals these publications 2-arachidonoylglycerol, tetrahydrocannabinol, anandamide. Together, comprise highly topic, literally molecular neuroscience at its “high”.

参考文章(55)
Vincenzo Di Marzo, Sravan K. Goparaju, Lei Wang, Jie Liu, Sándor Bátkai, Zoltán Járai, Filomena Fezza, Grant I. Miura, Richard D. Palmiter, Takayuki Sugiura, George Kunos, Leptin-regulated endocannabinoids are involved in maintaining food intake Nature. ,vol. 410, pp. 822- 825 ,(2001) , 10.1038/35071088
Ester Aso, Alexandre Sánchez-Pla, Esteban Vegas-Lozano, Rafael Maldonado, Isidro Ferrer, Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice. Journal of Alzheimer's Disease. ,vol. 43, pp. 977- 991 ,(2014) , 10.3233/JAD-141014
Nephi Stella, Paul Schweitzer, Daniele Piomelli, A second endogenous cannabinoid that modulates long-term potentiation Nature. ,vol. 388, pp. 773- 778 ,(1997) , 10.1038/42015
Rachel I. Wilson, Roger A. Nicoll, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature. ,vol. 410, pp. 588- 592 ,(2001) , 10.1038/35069076
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley, The orphan receptor GPR55 is a novel cannabinoid receptor British Journal of Pharmacology. ,vol. 152, pp. 1092- 1101 ,(2007) , 10.1038/SJ.BJP.0707460
Roger G. Pertwee, Endocannabinoids and Their Pharmacological Actions. Handbook of experimental pharmacology. ,vol. 231, pp. 1- 37 ,(2015) , 10.1007/978-3-319-20825-1_1
FERNANDO RODRIGUEZ DE FONSECA, MIRIAM SCHNEIDER, The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor. Addiction Biology. ,vol. 13, pp. 143- 146 ,(2008) , 10.1111/J.1369-1600.2008.00116.X
Luc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner, None, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The Lancet. ,vol. 365, pp. 1389- 1397 ,(2005) , 10.1016/S0140-6736(05)66374-X
Marek Sawzdargo, Tuan Nguyen, Dennis K Lee, Kevin R Lynch, Regina Cheng, Henry H.Q Heng, Susan R George, Brian F O'Dowd, Identification and cloning of three novel human G protein-coupled receptor genes GPR52, ΨGPR53 and GPR55: GPR55 is extensively expressed in human brain Molecular Brain Research. ,vol. 64, pp. 193- 198 ,(1999) , 10.1016/S0169-328X(98)00277-0